This month we interview Shijia Tang, principal scientist at Genentech, South San Francisco, CA, USA, about her innovative research focusing on the analysis of polymers and nanomaterials used in pharmaceutical analysis. Shijia decribes the benefits of an innovative in-line mixing modulation method for 2D-LC she developed for polymer and oligonucleotide analysis. The advantages of SEC–MALS to explore aggregation mechanisms for therapeutic constrained
peptides and mRNA-lipid nanoparticles and their aggregates are also discussed.
Shijia Teng is principal scientist at Genentech in South Francisco, CA, USA. Her research focuses on the analysis of polymers and nanomaterials used in pharmaceutical analysis. She has emerged as a key contributor in quantifying polymers in diverse pharmaceutical products, including amorphous solid dispersions and supramolecular hydrogels. Her research has enhanced the comprehension of polymer release kinetics and mechanisms in these intricate and emerging pharmaceutical formulations. She is an author of 15 publications including Journal of American Chemical Society, Analytical Chemistry, Journal of Chromatography A, and Molecular Pharmaceutics.
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.
AOAC International Awarded NIST Grant for Developing Drug Testing Standards
October 31st 2024The grant will be part of a new collaborative scientific initiative to address the need for standards that define the desired performance of lateral flow immunoassay test strips to detect illicit drugs in tablets and powders.